Phase 5 of a 31-Year Managed Symbiont Progression - A Longitudinal Case Study Interpreted Through the Biochemical Computer Framework
Abstract
This paper documents the final documented stage (January 2022–April 2026) of a 31-year progressive condition in a single subject. Over 80 diagnostic tests returned normal results while the subject experienced organ-by-organ vascular disconnection, volume depletion, metabolic pathway substitution, and structural tissue consumption — all invisible to standard medicine. Presented with contemporaneous labs, imaging, daily logs, and self-directed urinalysis, the record demonstrates that Candida albicans operates as a distributed biochemical computer capable of profound host regulation. Includes the dual-circulation oxygen paradox (venous O₂ sat 66% vs. pulse oximetry 100%), extreme pain tolerance with no outward signs, and multiple falsifiable predictions. The subject and author are the same individual. This is not theory — it is the physical evidence that the Homo candidus phenotype exists and can be managed, even when every conventional diagnostic framework fails. https://www.jimcraddock.com/
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 13 April 2026